Our Approach

Ardelyx develops:

  • Innovative, non-systemic, small molecule therapeutics that work exclusively in the GI tract to treat cardio-renal, GI and metabolic diseases.
  • We have developed a proprietary drug discovery and design platform enabling us, in a rapid and cost-efficient manner, to discover and design novel drug candidates

Targeted Therapeutic Areas

Ardelyx has established a unique approach to drug development with programs targeting gut transporters, receptors, and enzymes

Therapeutic Areas


Contact Information
Ardelyx, Inc.
34175 Ardenwood Blvd
Suite 100
Fremont, CA 94555
(510) 745-1700
Fax: 510-745-0493

• General:info@ardelyx.com.

• Media:media@ardelyx.com.

• Investor:investor@ardelyx.com.

• Employment:careers-1@ardelyx.com.

Please also visit our careers page.

•For Business Development, please contact: Mark Kaufmann, Chief Financial Officer – mkaufmann@ardelyx.com.